ANCN (ANCN) Stock Price, News & Analysis

Name: ANCN (ANCN) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

ANCN NASDAQ

Company Description

ANCN (NASDAQ: ANCN) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for ANCN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

Market Cap

Shares outstanding

Latest News

View All

March 15, 2021

+5.37%

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

acquisition

December 15, 2020

+87.01%

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement

acquisition

May 11, 2020

-14.03%

Anchiano Therapeutics Reports First Quarter 2020 Financial Results

earnings

May 5, 2020

+5.88%

Anchiano Appoints Steve DiPalma as Chief Financial Officer

management

ANCN has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, earnings, management. View all ANCN news →

SEC Filings

View All

No SEC filings available for ANCN.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ANCN Company Profile & Sector Positioning

ANCN (ANCN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.